- Home
- UCAR vs GOVX Comparison
UCAR vs GOVX Comparison
Compare UCAR & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UCAR
- GOVX
- Stock Information
- Founded
- UCAR 2013
- GOVX 2001
- Country
- UCAR China
- GOVX United States
- Employees
- UCAR N/A
- GOVX N/A
- Industry
- UCAR Retail-Auto Dealers and Gas Stations
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- UCAR Consumer Discretionary
- GOVX Health Care
- Exchange
- UCAR Nasdaq
- GOVX Nasdaq
- Market Cap
- UCAR 8.8M
- GOVX 7.6M
- IPO Year
- UCAR 2023
- GOVX N/A
- Fundamental
- Price
- UCAR $1.99
- GOVX $0.75
- Analyst Decision
- UCAR
- GOVX Strong Buy
- Analyst Count
- UCAR 0
- GOVX 4
- Target Price
- UCAR N/A
- GOVX $10.50
- AVG Volume (30 Days)
- UCAR 56.4K
- GOVX 770.4K
- Earning Date
- UCAR 10-07-2025
- GOVX 07-28-2025
- Dividend Yield
- UCAR N/A
- GOVX N/A
- EPS Growth
- UCAR N/A
- GOVX N/A
- EPS
- UCAR N/A
- GOVX N/A
- Revenue
- UCAR $6,067,871.00
- GOVX $6,143,044.00
- Revenue This Year
- UCAR N/A
- GOVX N/A
- Revenue Next Year
- UCAR N/A
- GOVX N/A
- P/E Ratio
- UCAR N/A
- GOVX N/A
- Revenue Growth
- UCAR 124.09
- GOVX 1943.07
- 52 Week Low
- UCAR $1.74
- GOVX $0.43
- 52 Week High
- UCAR $9.43
- GOVX $5.28
- Technical
- Relative Strength Index (RSI)
- UCAR 36.07
- GOVX 49.38
- Support Level
- UCAR $1.92
- GOVX $0.69
- Resistance Level
- UCAR $2.15
- GOVX $0.80
- Average True Range (ATR)
- UCAR 0.13
- GOVX 0.05
- MACD
- UCAR 0.06
- GOVX 0.01
- Stochastic Oscillator
- UCAR 56.16
- GOVX 59.10
About UCAR U Power Limited
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.